Novel Therapeutic Strategies Targeting Aberrant Cell Cycle Regulation in Pancreatic Cancer and Development of Robust Tissue-based Assay for Biomarkers of Therapeutic responsiveness

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/1039812

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

The overall aim of my research to assess noel therapeutic strategies in pancreatic cancer. Using new technology, more in depth understanding of pancreatic cancers (PC) is allowing better characterisation of these tumour into distinct molecular phenotypes. Some of these phenotypes are showing response to specific therapies in experimental models. Hence, there is an urgent need to to define these responsive phenotypes to stratify patients to appropriate therapeutic regimens.

Funded Activity Details

Start Date: 01-01-2012

End Date: 01-01-2016

Funding Scheme: Postgraduate Scholarships

Funding Amount: $139,177.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Solid Tumours

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

biomarkers | cancer | molecular biology | pancreas | pathology | treatment strategies

Related Links